Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Tandem Diabetes Care (TNDM) over the last 14 years, with Q3 2025 value amounting to $689.3 million.

  • Tandem Diabetes Care's Total Non-Current Liabilities rose 22.22% to $689.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $689.3 million, marking a year-over-year increase of 22.22%. This contributed to the annual value of $672.2 million for FY2024, which is 1070.41% up from last year.
  • As of Q3 2025, Tandem Diabetes Care's Total Non-Current Liabilities stood at $689.3 million, which was up 22.22% from $690.4 million recorded in Q2 2025.
  • In the past 5 years, Tandem Diabetes Care's Total Non-Current Liabilities ranged from a high of $729.8 million in Q1 2025 and a low of $412.6 million during Q1 2021
  • Moreover, its 5-year median value for Total Non-Current Liabilities was $601.8 million (2023), whereas its average is $591.1 million.
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first soared by 24614.91% in 2021, then decreased by 14.57% in 2023.
  • Over the past 5 years, Tandem Diabetes Care's Total Non-Current Liabilities (Quarter) stood at $454.2 million in 2021, then grew by 29.67% to $588.9 million in 2022, then grew by 3.1% to $607.2 million in 2023, then rose by 10.7% to $672.2 million in 2024, then increased by 2.55% to $689.3 million in 2025.
  • Its last three reported values are $689.3 million in Q3 2025, $690.4 million for Q2 2025, and $729.8 million during Q1 2025.